Which skeletal myoblasts and how to be transplanted for cardiac repair?

Biochemical and Biophysical Research Communications

Volumn 369, Issue 1, 2008, Pages 270-276

  Tezuka, Asaki ^a   Kawada, Tomie ^b   Nakazawa, Mikio ^c   Masui, Fujiko ^a   Konno, Satoshi ^d   Nitta, Shin ichi ^d   Toyo oka, Teruhiko ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c Faculty of Medicine   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Sarcoglycan; Cell transplantation; Connexin 43; Dilated cardiomyopathy; Fast twitch muscle; Fusion; Intercalated disc; Myosin heavy chain; Skeletal myoblast; Slow twitch muscle

Indexed keywords

CONNEXIN 43; DELTA SARCOGLYCAN; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSPLANTATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FAST MUSCLE FIBER; GENE EXPRESSION; HAMSTER; HEART ARRHYTHMIA; HEART MUSCLE CELL; HISTOCOMPATIBILITY; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLOW MUSCLE FIBER; TREATMENT OUTCOME;

ANIMALS; CARDIOMYOPATHIES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CRICETINAE; MALE; MUSCLE, SKELETAL; MYOBLASTS; MYOCYTES, CARDIAC; REGENERATION; TREATMENT OUTCOME;

CRICETINAE;

EID: 40849096427     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.084     Document Type: Article

References (32)

1. Leiden J.M. The genetics of dilated cardiomyopathy-Emerging clues to the puzzle. N Engl. J. Med. 337 (1997) 1080-1081
2. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4 (1998) 929-933
3. Menasche P., Hagège A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
4. Hagège A.A., Carrion C., Menasche P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361 (2003) 491-492
5. Menasche P., Hagège A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41 (2003) 1078-1083
6. Smits P.C., van Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J. Am. Coll. Cardiol. 42 (2003) 2063-2069
7. P. Menasche, First randomized placebo-controlled myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial. AHA scientific meetings late-breaking clinical trial session, Chicago, November 15, 2006.
8. Kawada T., Nakazawa M., Nakauchi S., et al. Rescue of hereditary form of dilated cardimyopathy by rAAV-mediated somatic gene therapy: amelioration of morphological findings, sarcolemma permeability, cardiac performances, and the prognosis of TO-2 hamsters. Proc. Natl. Acad. Sci. USA 99 (2002) 901-906
9. Toyo-oka T., Kawada T., Nakata J., et al. Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure. Proc Natl. Acad. Sci. USA 101 (2004) 7381-7385
10. Yoshida H., Takahashi M., Koshimizu M., et al. Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction. Cardiovasc. Res. 59 (2003) 419-427
11. 1 blocker on dystrophin-related proteins and calpain in failing heart. Cardiovasc. Res. 65 (2005) 356-365
12. Sakamoto A., Ono K., Abe M., et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster. Proc. Natl. Acad. Sci. USA 94 (1997) 13873-13878
13. Nigro V., Okazaki Y., Belsito A., et al. Identification of the Syrian hamster cardiomyopathy gene. Hum. Mol. Genet. 6 (1997) 601-607
14. Tsubata S., Bowles K.R., Vatta M., et al. Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J. Clin. Invest. 106 (2000) 655-662
15. Lapidos K.A., Chen Y.E., Earley J.U., et al. Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. J. Clin. Invest. 114 (2004) 1577-1585
16. Parmacek M.S., and Epstein J.A. Pursuing cardiac progenitors: regeneration redux. Cell 120 (2005) 295-298
17. Reinecke H., Poppa V., and Murray C.E. Skeletal muscle stem cells do not transdiffentiate into car diocytes after cardiac grafting. J. Mol. Cell. Cardiol. 34 (2002) 241-249
18. Rosenzweig A. Cardiac cell therapy-Mixed results from mixed cells. N. Engl. J. Med. 355 (2006) 1274-1277
19. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1199-1209
20. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355 (2006) 1210-1221
21. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 55 (2006) 1222-1232
22. Campbell K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80 (1995) 675-679
23. Kawada T., Masui F., Tezuka A., et al. A novel scheme of dystrophin disruption for the prgression of advanced heart failure. A review. Biochim. Biophys. Acta 1751 (2005) 73-81
24. Liu L.A., and Engvall E. Sarcoglycan isoforms in skeletal muscle. J. Biol. Chem. 274 (1999) 38171-38175
25. Xi H., Shin W.S., Suzuki J., et al. Dystrophin disruption might be related to myocardial cell apoptosis caused by isoproterenol. J. Cardiovasc. Pharmacol. 36 Suppl. 2 (2000) S25-S29
26. Yamauchi-Takihara K., Sole M.J., Liew J., et al. Characterization of human cardiac myosin heavy chain genes. Proc. Natl. Acad. Sci. USA 86 (1989) 3504-3508
27. Miyata S., Takemura G., Kawase Y., et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am. J. Pathol. 168 (2006) 386-397
28. Pouly J., Hagège A.A., Vilquin J.T., et al. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?. Circulation 110 (2004) 1626-1631
29. Attar N.A., Carrion C., Ghostine S., et al. Long-term functional and histological results of autologous skeletal muscle cells transplantation in rat. Cardiovasc. Res. 58 (2003) 142-148
30. Barclay C.J. Mechanical efficiency and fatigue of fast and slow muscles of the mouse. J. Physiol. 497 (1996) 781-794
31. Tezuka A., Kawada T., Nakazawa M., et al. Skeletal myoblast (SkM) transplantation to treat dilated cardiomyopathy (DCM) hamsters. J. Pharmacol. Sci. 94 Suppl. 1 (2004) 79p
32. Tezuka A., Kawada T., Nakazawa M., et al. Characterization of transplanted skeletal myoblast (SkM) to dilated cardiomyopathy (DCM) hamsters. J. Pharmacol. Sci. 97 Suppl. 1 (2005) 67p